Joanne Wuensch
Stock Analyst at Citigroup
(2.29)
# 645
Out of 5,319 analysts
408
Total ratings
60.19%
Success rate
19.85%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
COO Cooper Companies | Maintains: Buy | 115 110 | 79.51 | 38.35% | 18 | Mar 7, 2025 | |
ABT Abbott Laboratories | Maintains: Strong Buy | 135 160 | 130.98 | 22.16% | 20 | Mar 4, 2025 | |
DXCM DexCom | Maintains: Strong Buy | 101 104 | 68.57 | 51.67% | 13 | Mar 4, 2025 | |
SGHT Sight Sciences | Maintains: Neutral | 5 3 | 2.66 | 12.78% | 10 | Mar 4, 2025 | |
TNDM Tandem Diabetes Care | Downgrades: Neutral | 35 24 | 16.86 | 42.35% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 92 107 | 82.6 | 29.54% | 17 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 450 | 346.5 | 29.87% | 13 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 310 355 | 246.8 | 43.84% | 14 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 103 110 | 62.37 | 76.37% | 3 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 107 122 | 95.12 | 28.26% | 25 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 640 711 | 482.74 | 47.28% | 16 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 200 245 | 277.35 | -11.66% | 24 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 5 | 5.84 | -14.38% | 19 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 185 175 | 157.47 | 11.13% | 12 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 130 145 | 116.98 | 23.95% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 81 83 | 71.53 | 16.04% | 19 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 37 35 | 28.89 | 21.15% | 18 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 17 8 | 4.52 | 65.93% | 10 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 24 22 | 12.06 | 82.42% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 132 162 | 90.26 | 79.48% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 16 22 | 15.83 | 38.98% | 14 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 45 50 | 31.45 | 58.98% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 135 110 | 100.96 | 8.95% | 17 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 94 85 | 57.17 | 48.68% | 7 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 134 120 | 97.92 | 22.55% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 35 8 | 27.49 | -70.9% | 11 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 63 52 | n/a | n/a | 10 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 220 250 | 198.71 | 25.81% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 67 69 | 92.54 | -25.44% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 36 30 | n/a | n/a | 6 | Aug 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 109 127 | 212.91 | -40.35% | 5 | Dec 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 65 40 | n/a | n/a | 5 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 245 0 | n/a | n/a | 2 | Apr 25, 2017 |